Showing results (381-390 of 408) with videos related to

Sort By:
Pageof 41
The Lancet. Gastroenterology & Hepatology|May 9, 2021
Evaluation of hepatitis C treatment-as-prevention within Australian prisons (SToP-C): a prospective cohort studyBehzad Hajarizadeh, Jason Grebely, Marianne Byrne, et al.
The Lancet. Global Health|March 30, 2023
Epidemiology of injecting drug use, prevalence of injecting-related harm, and exposure to behavioural and environmental risks among people who inject drugs: a systematic reviewLouisa Degenhardt, Paige Webb, Samantha Colledge-Frisby, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|May 19, 2017
Hepatitis C virus core antigen: A simplified treatment monitoring tool, including for post-treatment relapseFrançois M J Lamoury, Angelica Soker, Danica Martinez, et al.
The International Journal on Drug Policy|June 22, 2017
Changes in risk behaviours during and following treatment for hepatitis C virus infection among people who inject drugs: The ACTIVATE studyHåvard Midgard, Behzad Hajarizadeh, Evan B Cunningham, et al.
The International Journal on Drug Policy|November 3, 2018
Acceptability and preferences of point-of-care finger-stick whole-blood and venepuncture hepatitis C virus testing among people who inject drugs in AustraliaSahar Bajis, Lisa Maher, Carla Treloar, et al.
The International Journal on Drug Policy|August 4, 2025
Patient preferences for simplified hepatitis C testing modalities among people at risk of hepatitis C infection in Australia: the SELECT studyAnnabelle Stevens, Jake Abbott, Loriate Gribbin, et al.
The Lancet. Gastroenterology & Hepatology|February 17, 2024
Direct-acting antiviral therapies for hepatitis C infection: global registration, reimbursement, and restrictionsAlison D Marshall, Alex R Willing, Abe Kairouz, et al.
The Journal of Investigative Dermatology|June 13, 2002
Relationship of neurologic degeneration to genotype in three xeroderma pigmentosum group G patientsSteffen Emmert, Hanoch Slor, David B Busch, et al.
Drug and Alcohol Dependence|June 30, 2022
Prevalence and factors associated with hospitalisation for bacterial skin infections among people who inject drugs: The ETHOS Engage StudyAlice Wheeler, Heather Valerio, Evan B Cunningham, et al.
The International Journal on Drug Policy|March 20, 2026
Reinfection following direct-acting antiviral therapy for hepatitis C infection among people in prison with recent injecting drug use: the SHARP-P studyAnna Conway, Jason Grebely, Shane Tillakeratne, et al.
Pageof 41